Season 25 Episode 20
Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
Published on 2 months, 4 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate